ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 106 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,408,744 | -38.0% | 205,656 | -6.2% | 0.05% | -39.0% |
| Q2 2023 | $2,272,471 | -29.0% | 219,139 | +23.3% | 0.08% | -48.8% |
| Q3 2021 | $3,199,000 | +366.3% | 177,740 | +354.7% | 0.16% | +492.6% |
| Q2 2021 | $686,000 | -88.0% | 39,089 | -82.8% | 0.03% | -85.3% |
| Q1 2021 | $5,718,000 | +865.9% | 226,887 | +148.3% | 0.18% | +513.3% |
| Q4 2020 | $592,000 | -41.9% | 91,376 | -77.0% | 0.03% | -56.5% |
| Q3 2020 | $1,019,000 | -38.4% | 396,500 | +550.3% | 0.07% | -23.3% |
| Q2 2017 | $1,654,000 | +13.5% | 60,975 | +24.8% | 0.09% | +25.0% |
| Q1 2017 | $1,457,000 | +27.2% | 48,875 | +15.9% | 0.07% | -5.3% |
| Q4 2016 | $1,145,000 | – | 42,173 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |